European Research
Initiative of ALK-related


The main task of the European Research Initiative on Anaplastic lymphoma kinase (ALK)-related malignancies (ERIA) is to strengthen cooperation and partnership of research groups focused on the role of ALK in cancer in order to accelerate scientific progress. With this aim in mind we anticipate that more efficacious and less toxic therapeutic strategies will be developed in the future through intense cooperation of involved partners.

We are grateful to the British Association for Cancer Research (BACR) and Leukaemia and Lymphoma Research for their generous support.
Laboratory for Immunological
and Molecular Cancer Research

IIIrd Medical Department with Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectiology of the Paracelsus
Medical University Salzburg
Prof. Richard Greil
Université Paul Sabatier
(Toulouse III)
CRCT - Le Centre de Recherches
en Cancérologie de Toulouse

Hospital S. Giovanni Battista   
Campus IFOM-IEO Milano    
Klinikum rechts der Isar
der TU München

III. Medizinische Klinik
und Poliklinik    
Medical University Vienna   

Charité Berlin    
Paracelsus Medical University

University of Oxford    

University of Cambridge    

Università degli Studi di Milano-Bicocca